<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36897808</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2326-5205</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Arthritis &amp; rheumatology (Hoboken, N.J.)</Title><ISOAbbreviation>Arthritis Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Ezh2 Knockout in B Cells Impairs Plasmablast Differentiation and Ameliorates Lupus-like Disease in MRL/lpr Mice.</ArticleTitle><Pagination><StartPage>1395</StartPage><EndPage>1406</EndPage><MedlinePgn>1395-1406</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/art.42492</ELocationID><Abstract><AbstractText Label="OBJECTIVES">EZH2 regulates B cell development and differentiation. We previously demonstrated increased EZH2 expression in peripheral blood mononuclear cells from lupus patients. The goal of this study was to evaluate the role of EZH2 expression in B cells in the pathogenesis of lupus.</AbstractText><AbstractText Label="METHODS">We generated an MRL/lpr mouse with floxed Ezh2, which was crossed with CD19-Cre mice to examine the effect of B cell EZH2 deficiency in MRL/lpr lupus-prone mice. Differentiation of B cells was assessed using flow cytometry. Single-cell RNA sequencing and single-cell B cell receptor sequencing were performed. In vitro B cell culture with an X-box binding protein 1 (XBP1) inhibitor was performed. EZH2 and XBP1 messenger RNA levels in CD19+ B cells isolated from lupus patients and healthy controls were analyzed.</AbstractText><AbstractText Label="RESULTS">We show that Ezh2 deletion in B cells significantly decreased autoantibody production and improved glomerulonephritis. B cell development was altered in the bone marrow and spleen of EZH2-deficient mice. Differentiation of germinal center B cells and plasmablasts was impaired. Single-cell RNA sequencing showed that XBP1, a key transcription factor in B cell development, is down-regulated in the absence of EZH2. Inhibiting XBP1 in vitro impairs plasmablast development similar to EZH2 deficiency in mice. Single-cell B cell receptor RNA sequencing revealed defective immunoglobulin class-switch recombination in EZH2-deficient mice. In human lupus B cells, we observed a strong correlation between EZH2 and XBP1 messenger RNA expression levels.</AbstractText><AbstractText Label="CONCLUSION">EZH2 overexpression in B cells contributes to disease pathogenesis in lupus.</AbstractText><CopyrightInformation>&#xa9; 2023 American College of Rheumatology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Xiaoqing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Rheumatology, Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dozmorov</LastName><ForeName>Mikhail G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Virginia Commonwealth University, Richmond, Virginia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strohlein</LastName><ForeName>Colleen E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Rheumatology, Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bastacky</LastName><ForeName>Sheldon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sawalha</LastName><ForeName>Amr H</ForeName><Initials>AH</Initials><Identifier Source="ORCID">0000-0002-3884-962X</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Rheumatology, Children's Hospital of Pittsburgh, Department of Medicine, Division of Rheumatology and Clinical Immunology, Lupus Center of Excellence, and Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI097134</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arthritis Rheumatol</MedlineTA><NlmUniqueID>101623795</NlmUniqueID><ISSNLinking>2326-5191</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011947">Receptors, Antigen, B-Cell</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.1.1.43</RegistryNumber><NameOfSubstance UI="D000071221">Enhancer of Zeste Homolog 2 Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="Y">Leukocytes, Mononuclear</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019463" MajorTopicYN="N">Mice, Inbred MRL lpr</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011947" MajorTopicYN="N">Receptors, Antigen, B-Cell</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071221" MajorTopicYN="Y">Enhancer of Zeste Homolog 2 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of interest:</b> None of the authors report any relevant financial conflict of interest</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>10</Day><Hour>12</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36897808</ArticleId><ArticleId IdType="mid">NIHMS1886074</ArticleId><ArticleId IdType="pmc">PMC10492897</ArticleId><ArticleId IdType="doi">10.1002/art.42492</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu H, Zhao M, Tan L, Lu Q. The key culprit in the pathogenesis of systemic lupus erythematosus: Aberrant DNA methylation. Autoimmunity reviews. 2016;15(7):684&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26970492</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohan C, Putterman C. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat Rev Nephrol. 2015;11(6):329&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">25825084</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedrich CM, Mabert K, Rauen T, Tsokos GC. DNA methylation in systemic lupus erythematosus. Epigenomics. 2017;9(4):505&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6040049</ArticleId><ArticleId IdType="pubmed">27885845</ArticleId></ArticleIdList></Reference><Reference><Citation>Coit P, Jeffries M, Altorok N, Dozmorov MG, Koelsch KA, Wren JD, et al. Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naive CD4+ T cells from lupus patients. J Autoimmun. 2013;43:78&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3790645</ArticleId><ArticleId IdType="pubmed">23623029</ArticleId></ArticleIdList></Reference><Reference><Citation>Coit P, Dozmorov MG, Merrill JT, McCune WJ, Maksimowicz-McKinnon K, Wren JD, et al. Epigenetic Reprogramming in Naive CD4+ T Cells Favoring T Cell Activation and Non-Th1 Effector T Cell Immune Response as an Early Event in Lupus Flares. Arthritis Rheumatol. 2016;68(9):2200&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5001909</ArticleId><ArticleId IdType="pubmed">27111767</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohraff DM, He Y, Farkash EA, Schonfeld M, Tsou PS, Sawalha AH. Inhibition of EZH2 Ameliorates Lupus-Like Disease in MRL/lpr Mice. Arthritis Rheumatol. 2019;71(10):1681&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6764871</ArticleId><ArticleId IdType="pubmed">31106974</ArticleId></ArticleIdList></Reference><Reference><Citation>McCabe MT, Graves AP, Ganji G, Diaz E, Halsey WS, Jiang Y, et al. Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27). Proc Natl Acad Sci U S A. 2012;109(8):2989&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3287005</ArticleId><ArticleId IdType="pubmed">22323599</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsou PS, Coit P, Kilian NC, Sawalha AH. EZH2 Modulates the DNA Methylome and Controls T Cell Adhesion Through Junctional Adhesion Molecule A in Lupus Patients. Arthritis Rheumatol. 2018;70(1):98&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5745285</ArticleId><ArticleId IdType="pubmed">28973837</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X, Tsou PS, Sawalha AH. Increased Expression of EZH2 Is Mediated by Higher Glycolysis and mTORC1 Activation in Lupus CD4(+) T Cells. Immunometabolism. 2020;2(2).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7213603</ArticleId><ArticleId IdType="pubmed">32395334</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhen Y, Smith RD, Finkelman FD, Shao WH. Ezh2-mediated epigenetic modification is required for allogeneic T cell-induced lupus disease. Arthritis Res Ther. 2020;22(1):133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7275547</ArticleId><ArticleId IdType="pubmed">32503684</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L, Jiang X, Qi C, Zhang C, Qu B, Shen N. EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice. Front Immunol. 2021;12:653989.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8044841</ArticleId><ArticleId IdType="pubmed">33868295</ArticleId></ArticleIdList></Reference><Reference><Citation>Ih Su, Basavaraj A, Krutchinsky AN, Hobert O, Ullrich A, Chait BT, et al. Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nature Immunology. 2003;4(2):124&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">12496962</ArticleId></ArticleIdList></Reference><Reference><Citation>Beguelin W, Popovic R, Teater M, Jiang Y, Bunting KL, Rosen M, et al. EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell. 2013;23(5):677&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3681809</ArticleId><ArticleId IdType="pubmed">23680150</ArticleId></ArticleIdList></Reference><Reference><Citation>Domeier PP, Schell SL, Rahman ZS. Spontaneous germinal centers and autoimmunity. Autoimmunity. 2017;50(1):4&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5669068</ArticleId><ArticleId IdType="pubmed">28166685</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal M, Powers SE, Maienschein-Cline M, Bartom ET, Hamel KM, Kee BL, et al. Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2. Nature Immunology. 2011;12(12):1212&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3233979</ArticleId><ArticleId IdType="pubmed">22037603</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M, Price MJ, Patterson DG, Barwick BG, Haines RR, Kania AK, et al. EZH2 Represses the B Cell Transcriptional Program and Regulates Antibody-Secreting Cell Metabolism and Antibody Production. J Immunol. 2018;200(3):1039&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5780247</ArticleId><ArticleId IdType="pubmed">29288200</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Iwata S, Hajime M, Ohkubo N, Todoroki Y, Miyata H, et al. Methionine Commits Cells to Differentiate Into Plasmablasts Through Epigenetic Regulation of BTB and CNC Homolog 2 by the Methyltransferase EZH2. Arthritis Rheumatol. 2020;72(7):1143&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">31961063</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwata S, Yamaoka K, Niiro H, Jabbarzadeh-Tabrizi S, Wang SP, Kondo M, et al. Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus. Lupus. 2015;24(7):695&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pubmed">25432781</ArticleId></ArticleIdList></Reference><Reference><Citation>Teichmann LL, Kashgarian M, Weaver CT, Roers A, M&#xfc;ller W, Shlomchik MJ. B cell-derived IL-10 does not regulate spontaneous systemic autoimmunity in MRL. Faslpr mice. The Journal of Immunology. 2012;188(2):678&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3253138</ArticleId><ArticleId IdType="pubmed">22156495</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilstra JS, John S, Gordon RA, Leibler C, Kashgarian M, Bastacky S, et al. B cell&#x2013;intrinsic TLR9 expression is protective in murine lupus. The Journal of Clinical Investigation. 2020;130(6):3172&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7260024</ArticleId><ArticleId IdType="pubmed">32191633</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM 3rd, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;177(7):1888&#x2013;902.e21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6687398</ArticleId><ArticleId IdType="pubmed">31178118</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biology. 2004;5(10):R80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC545600</ArticleId><ArticleId IdType="pubmed">15461798</ArticleId></ArticleIdList></Reference><Reference><Citation>Cross Benedict CS, Bond Peter J, Sadowski Pawel G, Jha Babal K, Zak J, Goodman Jonathan M, et al. The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule. Proceedings of the National Academy of Sciences. 2012;109(15):E869&#x2013;E78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3326519</ArticleId><ArticleId IdType="pubmed">22315414</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutcheson J, Scatizzi JC, Siddiqui AM, Haines GK, Wu T, Li Q-Z, et al. Combined Deficiency of Proapoptotic Regulators Bim and Fas Results in the Early Onset of Systemic Autoimmunity. Immunity. 2008;28(2):206&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">18275831</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker AM, Dao KH, Han BK, Kornu R, Lakhanpal S, Mobley AB, et al. SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature. PLoS One. 2013;8(6):e67003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3691135</ArticleId><ArticleId IdType="pubmed">23826184</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerutti A, Cols M, Puga I. Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nature Reviews Immunology. 2013;13(2):118&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3652659</ArticleId><ArticleId IdType="pubmed">23348416</ArticleId></ArticleIdList></Reference><Reference><Citation>Akkaya M, Kwak K, Pierce SK. B cell memory: building two walls of protection against pathogens. Nature Reviews Immunology. 2020;20(4):229&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7223087</ArticleId><ArticleId IdType="pubmed">31836872</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew NR, Jayanthan JK, Smirnov IV, Robinson JL, Axelsson H, Nakka SS, et al. Single-cell BCR and transcriptome analysis after influenza infection reveals spatiotemporal dynamics of antigen-specific B cells. Cell Rep. 2021;35(12):109286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7612943</ArticleId><ArticleId IdType="pubmed">34161770</ArticleId></ArticleIdList></Reference><Reference><Citation>Palm A-KE, Kleinau S. Marginal zone B cells: From housekeeping function to autoimmunity? Journal of Autoimmunity. 2021;119:102627.</Citation><ArticleIdList><ArticleId IdType="pubmed">33640662</ArticleId></ArticleIdList></Reference><Reference><Citation>Laidlaw BJ, Duan L, Xu Y, Vazquez SE, Cyster JG. The transcription factor Hhex cooperates with the corepressor Tle3 to promote memory B cell development. Nat Immunol. 2020;21(9):1082&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7442689</ArticleId><ArticleId IdType="pubmed">32601467</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya D, Cheah MT, Franco CB, Hosen N, Pin CL, Sha WC, et al. Transcriptional profiling of antigen-dependent murine B cell differentiation and memory formation. J Immunol. 2007;179(10):6808&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4517294</ArticleId><ArticleId IdType="pubmed">17982071</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallies A, Hasbold J, Tarlinton DM, Dietrich W, Corcoran LM, Hodgkin PD, et al. Plasma Cell Ontogeny Defined by Quantitative Changes in Blimp-1 Expression. Journal of Experimental Medicine. 2004;200(8):967&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2211847</ArticleId><ArticleId IdType="pubmed">15492122</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HTT, Guevarra RB, Magez S, Radwanska M. Single-cell transcriptome profiling and the use of AID deficient mice reveal that B cell activation combined with antibody class switch recombination and somatic hypermutation do not benefit the control of experimental trypanosomosis. PLoS Pathog. 2021;17(11):e1010026.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8610246</ArticleId><ArticleId IdType="pubmed">34762705</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y, Iqbal J, Xiao L, Lynch RC, Rosenwald A, Staudt LM, et al. Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs. BMC Immunol. 2004;5:20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC535350</ArticleId><ArticleId IdType="pubmed">15369600</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson SM, Tomayko MM, Ahuja A, Haberman AM, Shlomchik MJ. New markers for murine memory B cells that define mutated and unmutated subsets. Journal of Experimental Medicine. 2007;204(9):2103&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2118690</ArticleId><ArticleId IdType="pubmed">17698588</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrhardt GRA, Hijikata A, Kitamura H, Ohara O, Wang J-Y, Cooper MD. Discriminating gene expression profiles of memory B cell subpopulations. J Exp Med. 2008;205(8):1807&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2525601</ArticleId><ArticleId IdType="pubmed">18625746</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkiel S, Barlev AN, Atisha-Fregoso Y, Suurmond J, Diamond B. Plasma Cell Differentiation Pathways in Systemic Lupus Erythematosus. Front Immunol. 2018;9:427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5845388</ArticleId><ArticleId IdType="pubmed">29556239</ArticleId></ArticleIdList></Reference><Reference><Citation>Roco JA, Mesin L, Binder SC, Nefzger C, Gonzalez-Figueroa P, Canete PF, et al. Class-Switch Recombination Occurs Infrequently in Germinal Centers. Immunity. 2019;51(2):337&#x2013;50.e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6914312</ArticleId><ArticleId IdType="pubmed">31375460</ArticleId></ArticleIdList></Reference><Reference><Citation>Durandy A, Kracker S. Immunoglobulin class-switch recombination deficiencies. Arthritis Res Ther. 2012;14(4):218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3580555</ArticleId><ArticleId IdType="pubmed">22894609</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee WS, Amengual O. B cells targeting therapy in the management of systemic lupus erythematosus. Immunol Med. 2020;43(1):16&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">32107989</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutt SL, Keenan C, Chopin M, Allan RS. EZH2 function in immune cell development. Biol Chem. 2020;401(8):933&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">32045348</ArticleId></ArticleIdList></Reference><Reference><Citation>Caganova M, Carrisi C, Varano G, Mainoldi F, Zanardi F, Germain PL, et al. Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis. J Clin Invest. 2013;123(12):5009&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3859423</ArticleId><ArticleId IdType="pubmed">24200695</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesin L, Schiepers A, Ersching J, Barbulescu A, Cavazzoni CB, Angelini A, et al. Restricted Clonality and Limited Germinal Center Reentry Characterize Memory B Cell Reactivation by Boosting. Cell. 2020;180(1):92&#x2013;106 e11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6958527</ArticleId><ArticleId IdType="pubmed">31866068</ArticleId></ArticleIdList></Reference><Reference><Citation>Takemori T, Kaji T, Takahashi Y, Shimoda M, Rajewsky K. Generation of memory B cells inside and outside germinal centers. European Journal of Immunology. 2014;44(5):1258&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">24610726</ArticleId></ArticleIdList></Reference><Reference><Citation>Reimold AM, Iwakoshi NN, Manis J, Vallabhajosyula P, Szomolanyi-Tsuda E, Gravallese EM, et al. Plasma cell differentiation requires the transcription factor XBP-1. Nature. 2001;412(6844):300&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11460154</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyagawa-Hayashino A, Yoshifuji H, Kitagori K, Ito S, Oku T, Hirayama Y, et al. Increase of MZB1 in B cells in systemic lupus erythematosus: proteomic analysis of biopsied lymph nodes. Arthritis Research &amp; Therapy. 2018;20(1):13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5791339</ArticleId><ArticleId IdType="pubmed">29382365</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu TP, Hong YH, Tung KY, Yang PM. In silico and experimental analyses predict the therapeutic value of an EZH2 inhibitor GSK343 against hepatocellular carcinoma through the induction of metallothionein genes. Oncoscience. 2016;3(1):9&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4751912</ArticleId><ArticleId IdType="pubmed">26973856</ArticleId></ArticleIdList></Reference><Reference><Citation>Ise W, Kohyama M, Schraml BU, Zhang T, Schwer B, Basu U, et al. The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells. Nat Immunol. 2011;12(6):536&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3117275</ArticleId><ArticleId IdType="pubmed">21572431</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochiai K, Kondo H, Okamura Y, Shima H, Kurokochi Y, Kimura K, et al. Zinc finger&#x2013;IRF composite elements bound by Ikaros/IRF4 complexes function as gene repression in plasma cell. Blood Advances. 2018;2(8):883&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5915997</ArticleId><ArticleId IdType="pubmed">29669755</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavnezer J, Guikema JEJ, Schrader CE. Mechanism and Regulation of Class Switch Recombination. Annual Review of Immunology. 2008;26(1):261&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707252</ArticleId><ArticleId IdType="pubmed">18370922</ArticleId></ArticleIdList></Reference><Reference><Citation>F&#xf6;rger F, Matthias T, Oppermann M, Becker H, Helmke K. Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis. Lupus. 2004;13(1):36&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">14870916</ArticleId></ArticleIdList></Reference><Reference><Citation>Witte T. IgM Antibodies Against dsDNA in SLE. Clinical Reviews in Allergy &amp; Immunology. 2008;34(3):345&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">18097774</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuyama E, Suarez-Fueyo A, Bradley SJ, Mizui M, Marin AV, Mulki L, et al. The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections. Cell Rep. 2020;30(1):112&#x2013;23 e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577012</ArticleId><ArticleId IdType="pubmed">31914379</ArticleId></ArticleIdList></Reference><Reference><Citation>Eich M-L, Athar M, Ferguson JE III, Varambally S. EZH2-Targeted Therapies in Cancer: Hype or a Reality. Cancer Research. 2020;80(24):5449&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8323716</ArticleId><ArticleId IdType="pubmed">32978169</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KH, Roberts CWM. Targeting EZH2 in cancer. Nature Medicine. 2016;22(2):128&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4918227</ArticleId><ArticleId IdType="pubmed">26845405</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng J, Zhang J, Sun Y, Wang J, Ren C, Banerjee S, et al. Targeting EZH2 for cancer therapy: From current progress to novel strategies. European Journal of Medicinal Chemistry. 2022;238:114419.</Citation><ArticleIdList><ArticleId IdType="pubmed">35569264</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>